Even as the FDA threatens sellers of nano-silver for claiming their products are anti-bacterial, Corning creates a new glass for smartphones and tablets that uses nano-silver as an anti-bacterial!
Beautiful and reproducible test!
Does the Silver ion glass reduce bacterial activity? Yes or No?
Can Silver ions be ingested safely? Yes or No?
As we are doing NO harm – Hippocratic oath – with Silver, can we test it as a possible solution to Ebola?
The answer? of course NOT! The global pharma fraud must be maintained.
A £3.2 million grant from the Wellcome Trust will enable multiple partners around the world to quickly establish clinical trials at existing Ebola treatment centres. Partners include the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC), the University of Oxford, Médecins Sans Frontières (MSF), the World Health Organization (WHO), Institut Pasteur, Institut Pasteur de Dakar, Fondation Mérieux and the Global Health Network.
In August a WHO expert panel unanimously concluded that in such exceptional circumstances it would be ethical to evaluate unregistered investigational treatments in people with Ebola virus disease.
Several potential interventions have shown promise in the laboratory, in animal studies on non-human primates, and in a small number of cases of compassionate intervention, but none has yet been tested for efficacy and safety in humans with Ebola. Any new drug needs to be evaluated within the rigorous settings of a clinical trial to assess whether it is doing more harm or good.
The belief system of the global medical system cannot entertain the simpler solutions. We can with high confidence state, that Intravenous Vitamin C, collodial/nano silver and natural antiviral oils would be safer as treatment protocols and would provide the validation of these solutions that these medical priests state they seek for corporate “unregistered investigational treatment”.
Further evidence of the collusion of academia and funding foundations in the fraud that are vaccines.
The 15-minute Ebola test is six times faster than similar tests currently in use and aims to speed up the diagnosis of Ebola cases. Early detection of Ebola leads to better infection control as medical staff can identify and isolate confirmed cases of Ebola faster, and start treating patients sooner. Ultimately, a faster test could reduce Ebola transmission and mortality.
The project is supported through a joint Department for International Development (DFID) and Wellcome Trust fund for rapid health research during the Ebola outbreak. The six projects are managed by Enhancing Learning & Research for Humanitarian Assistance (ELRHA).
The trial, led by researchers at the Pasteur Institute in Dakar, Senegal, will be deployed using a ‘mobile suitcase laboratory’ which is designed for low-resource settings. The portable laboratory includes a solar panel, a power pack and a results reader which is the size of a small laptop.
The reagents used in the test are available as dried pellets, which are ‘cold-chain-independent’, meaning that they can be used and transported at room temperature. Similarly to the tests currently in use, the new test detects the genetic material of the virus. The pilot trial will test whether the reagents are safe and effective to use with Ebola patients’ blood and saliva samples…
Published on Nov 18, 2014
The Ebola outbreak is once again, branching off into a new direction. Both here in the U.S., and overseas. In West Africa, another country is on high alert. Mali’s government ordered a massive quarantine, forcing more than 600 people to leave their family and friends. While here in the US, we’re learning the second patient to die from Ebola could have actually have been misdiagnosed. One man we’ve talked to throughout this whole story saw this coming months ago. He told us about the Ebola tests and the likelihood of false positives. Today, we welcome Robert Scott Bell back to the broadcast, to catch up to speed on the Ebola story.
Dr. Martin Salia, 44, who arrived Saturday from West Africa in dire health, was pronounced dead Monday morning from the virus. He reportedly tested negative for the virus despite having been in the throes of infection.
The Washington Post reported the following:
Salia was treated with the blood of an Ebola survivor as well as the experimental treatment ZMapp, which was initiated on Saturday, the hospital said. When he arrived in Nebraska on Saturday, he was already suffering from kidney and respiratory failure. He died at about 4 a.m. local time, according to the hospital.
Intravenous vitamin C should be given to all Ebola patients. Though it has not been studied, I have no doubt that IV vitamin C would be a great benefit to any patient suffering not only from Ebola but from any infectious agent. In my practice, I have used IV vitamin C for over 20 years. Anytime the body is stressed, vitamin C requirements are elevated. IV vitamin C achieves a much higher serum level as compared to oral vitamin C. IV vitamin C should be a standard-of-care treatment for all Ebola patients. In fact, it should be standard-of-care for any hospitalized patient.
Doctors at the Frankfurt University Hospital said the patient, who was medically evacuated to Frankfurt after working with Ebola victims in Sierra Leone, recovered after receiving the drug called FX06, developed by scientists at the Vienna General Hospital in Austria.
Rather than attacking the virus, the Frankfurt hospital said the treatment focused on mitigating the damage to organs caused by the pathogen
“Patients need to survive for 10 to 12 days until their body has enough time to develop antibodies to Ebola,” said Timo Wolf, the infectious diseases specialist who treated the patient
“Potential Ebola treatments include Avigan, or favipiravir, from Japan’s Fujifilm, which was originally developed as a flu drug; a medicine called ZMapp developed by Mapp Biopharmaceuticals in the United States; and a fourth potential drug called TKM-Ebola, being developed by Tekmira.”
Further confirmation that allopathic (conventional) doctors are wedded to the corporate (expensive) solutions.
Nurse Pineo, the first white that survived the Lassa fever (another hemorrhagic fever) outbreak in Lassa, was, on her own, taking vitamins (Fuller, JG. Fever. Reader’s Digest Press. 1974.) Of course that was ignored and they used her convalescent serum for subsequent cases of Lassa fever in medical personnel.
WRH – Mike Rivero (http://whatreallyhappened.com) comment:
Despite the WHO authorizing the use of unproven treatments to deal with the Ebola the reality is that only treatments from the giant pharmaceutical corporations are being allowed. The FDA, still looking at Ebola from the economic point of view, is coming down hard on anyone offering treatments from which the pharmaceutical corporations cannot make the profit.
We know the FDA is blocking use of even mention of nano silver products wherever they can, despite the fact that both http://whatreallyhappened.com have told the US Government to shove their regulations (possibly in response to the growing awareness that the US Government may have triggered the Ebola outbreak in Africa with a botched vaccine trial) and are treating Ebola patients with nano-silver and reporting positive results.
That being said, it was observed during the 1918 flu pandemic (also triggered by a botched vaccine trial) that workers at a factory that processed cinnamon for bakeries did not come down with the flu. This triggered widespread use of cinnamon, usually mixed with milk, which did in fact lower the fever and reduce symptoms of those already infected with the flu. Most naturally occurring antibiotics are broad spectrum, which means they are effective against a wide variety of infections, whereas modern pharmaceutical antibiotics are designed to be effective against specific infectious agents and are usually useless against others.
So do your own research and make your own choices.
After all, are you willing to bet your life the government, media, and pharmaceutical corporations are telling you the truth?